Skip to main content
. 2020 Nov 25;11:577971. doi: 10.3389/fneur.2020.577971

Table 1.

Patient characteristics.

Variable Patient group (N = 27) Control group (N = 19)
Age [Years, Mean ± SD] 70.2 ± 13.4 67.2 ± 9.3
Sex [as % female] 40.7 31.6
Co-morbidities
Hypertension [n (%)] 23 (85.19) 15 (78.95)
Diabetes mellitus [n (%)] 10 (37.04) 8 (42.11)
Stroke characteristics
Etiology
Large-artery atherosclerosis [n (%)] 3 (11.11) NA$
Cardio embolism [n (%)] 9 (33.33) NA$
Stroke of other determined etiology [n (%)] 5 (18.52) NA$
Stroke of undetermined etiology [n (%)] 10 (37.04) NA$
1. MRI Stroke Size* [ml3, Median (IQR)] 2,88 (4.83) NA$
Initial NIHSS [Median (IQR)] 11 (7) NA$
NIHSS at discharge [Median (IQR)] 4 (7.5)
Infarct side [n (%) left sided infarcts] 19 (70.37) NA$
Treatment [n (%)] 19 (70.37) NA$
Systemic Thrombolysis [n (%)]& 17 (89.47) NA$
Mechanical Thrombectomy [n (%)]& 10 (52.63) NA$
Combined Treatment [n (%)]& 8 (42.11) NA$
&

The numbers of systemic thrombolysis and mechanical thrombectomies are the total number of patients receiving the treatments and include patients receiving a combination of both.

$

NA, Not applicable.

*

Stroke size could be determined in 7 out of the 27 patients.